Skip to main content

Research Repository

Advanced Search

Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives

Armstrong, Tom; Lamont, Malcolm; Lanne, Alice; Alderwick, Luke J.; Thomas, Neil R.

Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives Thumbnail


Authors

Tom Armstrong

Malcolm Lamont

Alice Lanne

Luke J. Alderwick

NEIL THOMAS neil.thomas@nottingham.ac.uk
Professor of Medicinal and Biological Chemistry



Abstract

Multi-drug resistant tuberculosis (MDR-TB) represents a growing problem for global healthcare systems. In addition to 1.3 million deaths in 2018, the World Health Organisation reported 484,000 new cases of MDR-TB. Isoniazid is a key anti-TB drug that inhibits InhA, a crucial enzyme in the cell wall biosynthesis pathway and identical in Mycobacterium tuberculosis and M. bovis. Isoniazid is a pro-drug which requires activation by the enzyme KatG, mutations in KatG prevent activation and confer INH-resistance. ‘Direct inhibitors’ of InhA are attractive as they would circumvent the main clinically observed resistance mechanisms. A library of new 1,5-triazoles, designed to mimic the structures of both triclosan molecules uniquely bound to InhA have been synthesised. The inhibitory activity of these compounds was evaluated using isolated enzyme assays with 2 (5-chloro-2-(4-(5-(((4-(4-chloro-2-hydroxyphenoxy)benzyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenoxy)phenol) exhibiting an IC50 of 5.6 µM. Whole-cell evaluation was also performed, with 11 (5-chloro-2-(4-(5-(((4-(cyclopropylmethoxy)benzyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenoxy)phenol) showing the greatest potency, with an MIC99 of 12.9 µM against M. bovis.

Journal Article Type Article
Acceptance Date Aug 27, 2020
Online Publication Date Sep 8, 2020
Publication Date Nov 15, 2020
Deposit Date Oct 14, 2020
Publicly Available Date Sep 9, 2021
Journal Bioorganic & Medicinal Chemistry
Print ISSN 0968-0896
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 28
Issue 22
Article Number 115744
DOI https://doi.org/10.1016/j.bmc.2020.115744
Keywords Organic Chemistry; Clinical Biochemistry; Molecular Medicine; Biochemistry; Molecular Biology; Drug Discovery; Pharmaceutical Science
Public URL https://nottingham-repository.worktribe.com/output/4963509
Publisher URL https://www.sciencedirect.com/science/article/abs/pii/S0968089620305745

Files





You might also like



Downloadable Citations